![Tara Mccarthy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tara Mccarthy
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Tara Mccarthy
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tara Mccarthy
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
AMERICAN SUPERCONDUCTOR CORPORATION | Electrical Products | Investor Relations Contact | |
ICTS INTERNATIONAL N.V. | Other Transportation | Director of Finance/CFO | |
REIT Management & Research LLC
![]() REIT Management & Research LLC Real Estate Investment TrustsFinance REIT Management & Research LLC provides real estate services. It manages real estate funds for its clients. The company was founded by Barry Michael Portnoy in 1986 and is headquartered in Newton, MA. | Real Estate Investment Trusts | Public Communications Contact | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Medical Specialties | Director of Finance/CFO | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
OFFICE PROPERTIES INCOME TRUST | Real Estate Investment Trusts | Public Communications Contact | |
Clinical Ink, Inc.
![]() Clinical Ink, Inc. Internet Software/ServicesTechnology Services Clinical Ink, Inc. provides electronic source solutions for clinical research sites. Its solutions include data management, monitoring, clinical sites and patient centric. The company was founded by Douglas E. Pierce Jr. and Tommy Littlejohn on July 19, 2006 and is headquartered in Winston-Salem, NC. | Internet Software/Services | Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
George Washington University | College/University | Undergraduate Degree | |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Huntleigh USA Corp.
![]() Huntleigh USA Corp. Miscellaneous Commercial ServicesCommercial Services Huntleigh USA Corp. provides security solutions for individuals and businesses. The firm offers active site monitoring, advanced technology solutions, video surveillance-as-a service, professional security and aviation & related services. It provides limited security services, such as charter flight and cargo screening, for airlines, as well as skycap, agent and special service personnel. The company was founded in 1992 and is headquartered in Irving, TX. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Whitehead Institute for Biomedical Research
![]() Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ORAMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Solel Solar Systems Ltd.
![]() Solel Solar Systems Ltd. Engineering & ConstructionIndustrial Services Solel Solar Systems Ltd. provides solar thermal power services. It designs, manufactures and installs turnkey solar fields for large scale power generation. It offers technology for new solar power plants in the US, Spain and other sun-rich locations. Solel's technology converts sunshine into useful thermal energy, and subsequently into electricity, by way of parabolic mirrors that concentrate the solar energy onto solar thermal receivers containing a heat transfer fluid. It was founded in 1992 and is headquartered in Beit Shemesh, IL. | Engineering & Construction | Director of Finance/CFO | |
KAMADA LTD. | Biotechnology | Director of Finance/CFO | |
German Cancer Research Center
![]() German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
Amgen Canada, Inc.
![]() Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Biotechnology | Corporate Officer/Principal | |
EPIZYME, INC. | Biotechnology | Investor Relations Contact | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The College of Management Academic Studies | College/University | Undergraduate Degree | |
AXCA HEALPAR | Biotechnology | Investor Relations Contact | |
The Leon Recanati Graduate School of Business Administration | College/University | Masters Business Admin | |
University of Rochester Simon Business School | College/University | Masters Business Admin | |
OSS Healthcare, Inc. | Director/Board Member | ||
TriNetX, LLC
![]() TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Florida Healthcare Analytics, Inc.
![]() Florida Healthcare Analytics, Inc. Packaged SoftwareTechnology Services Part of Clinical Ink, Inc., Florida Healthcare Analytics, Inc. provides mobile applications for clinical trial patient engagement and electronic patient reported outcomes. The company is based in Boston, MA. The company was founded by Jeremy Sohn. Florida Healthcare Analytics was acquired by Clinical Ink, Inc. on March 29, 2015. | Packaged Software | Director/Board Member | |
PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
MPM Oncology Impact Management LP
![]() MPM Oncology Impact Management LP Investment ManagersFinance MPM Oncology Impact Management LP (OIM) is a hedge fund management firm headquartered in Cambridge, Massachusetts. The firm is a subsidiary of MPM Oncology Impact Management GP LLC, which is owned by MPM Capital, Inc. OIM provides investment supervisory services to investment vehicles. | Investment Managers | Corporate Officer/Principal | |
UBS Oncology Impact Fund
![]() UBS Oncology Impact Fund Investment ManagersFinance UBS Oncology Impact Fund is an American private company located in Cambridge, MA, with a presence in the Cayman Islands, that functions as a family of funds. | Investment Managers | Director/Board Member | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
ALLOVIR, INC. | Biotechnology | Director/Board Member | |
MPM Sunstates GP Managing Member LLC | Corporate Officer/Principal | ||
ElevateBio LLC
![]() ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Cullinan Pearl Corp.
![]() Cullinan Pearl Corp. BiotechnologyHealth Technology Part of Otsuka Holdings Co., Ltd., Cullinan Pearl Corp. is a company that develops an orally available tyrosine kinase inhibitor. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. Cullinan Pearl was acquired by Taiho Pharmaceutical Co., Ltd. from Cullinan Oncology, Inc. on June 23, 2022 for $405 million. | Biotechnology | Director/Board Member | |
ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Nextpoint Therapeutics, Inc.
![]() Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Orna Therapeutics, Inc.
![]() Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chairman | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Bioimpact Capital LLC
![]() Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Reunion Neuroscience, Inc.
![]() Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Renagade Therapeutics, Inc.
![]() Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder |
Statistik
International
Vereinigte Staaten | 41 |
Israel | 7 |
Kanada | 3 |
Niederlande | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 24 |
Finance | 8 |
Consumer Services | 6 |
Health Services | 4 |
Commercial Services | 4 |
Operativ
Director/Board Member | 52 |
Corporate Officer/Principal | 18 |
Independent Dir/Board Member | 10 |
Chief Executive Officer | 9 |
Chairman | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Ansbert Gadicke | 56 |
Mark Leuchtenberger | 21 |
Chaime Orlev | 10 |
Jason Fredette | 9 |
Anand Varadan | 9 |
- Börse
- Insiders
- Tara Mccarthy
- Unternehmensverbindungen